StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical r&d expenses

Research and development expenses are spending on new products and technology.

Aethlon Medical's R&D Expenses for the twelve months ending Mar 31, 2026 was $1.91M, down 13.6% year over year. For fiscal 2026 it was $1.91M, down 13.6% from the year before. Over ten years it grew 9.4% a year on average. The highest annual figure on record is $2.75M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.91M-13.6%
FY2025Mar 31, 2025$2.21M-12.2%
FY2024Mar 31, 2024$2.52M-8.2%
FY2023Mar 31, 2023$2.75M+17.3%
FY2022Mar 31, 2022$2.34M+13.0%
FY2021Mar 31, 2021$2.07M+123.5%
FY2020Mar 31, 2020$927.00K+3.5%
FY2019Mar 31, 2019$896.00K+52.9%
FY2018Mar 31, 2018$586.00K-12.9%
FY2017Mar 31, 2017$673.00K-13.9%
FY2016Mar 31, 2016$782.00K-23.9%
FY2015Mar 31, 2015$1.03M-31.9%
FY2014Mar 31, 2014$1.51M+4.8%
FY2013Mar 31, 2013$1.44M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$549.00K+128.6%
Q4 FY2026CQ1 2026Mar 31, 2026$589.98K+125.6%
Q1 FY2026CQ2 2025Jun 30, 2025$524.00K+26.4%
Q4 FY2025CQ1 2025Mar 31, 2025$1.33M+106.0%
Q3 FY2025CQ4 2024Dec 31, 2024$240.20K-59.5%
Q2 FY2025CQ3 2024Sep 30, 2024$261.49K-58.4%
Q1 FY2025CQ2 2024Jun 30, 2024$414.66K-38.9%
Q4 FY2024CQ1 2024Mar 31, 2024$644.89K+4.8%
Q3 FY2024CQ4 2023Dec 31, 2023$593.40K+6.3%
Q2 FY2024CQ3 2023Sep 30, 2023$628.45K-26.3%
Q1 FY2024CQ2 2023Jun 30, 2023$678.92K-20.9%
Q4 FY2023CQ1 2023Mar 31, 2023$615.62K-34.3%
Q3 FY2023CQ4 2022Dec 31, 2022$558.22K+57.4%
Q2 FY2023CQ3 2022Sep 30, 2022$852.46K+78.3%
Q1 FY2023CQ2 2022Jun 30, 2022$858.35K+46.1%
Q4 FY2022CQ1 2022Mar 31, 2022$937.11K+33.0%
Q3 FY2022CQ4 2021Dec 31, 2021$354.57K-23.1%
Q2 FY2022CQ3 2021Sep 30, 2021$478.20K-6.0%
Q1 FY2022CQ2 2021Jun 30, 2021$587.69K+55.8%
Q4 FY2021CQ1 2021Mar 31, 2021$704.67K+199.9%
Q3 FY2021CQ4 2020Dec 31, 2020$461.18K+111.0%
Q2 FY2021CQ3 2020Sep 30, 2020$508.90K+128.4%
Q1 FY2021CQ2 2020Jun 30, 2020$377.17K+51.6%
Q4 FY2020CQ1 2020Mar 31, 2020$234.98K-2.2%
Q3 FY2020CQ4 2019Dec 31, 2019$218.57K-10.4%
Q2 FY2020CQ3 2019Sep 30, 2019$222.86K+24.6%
Q1 FY2020CQ2 2019Jun 30, 2019$248.87K+27.8%
Q4 FY2019CQ1 2019Mar 31, 2019$240.24K+94.7%
Q3 FY2019CQ4 2018Dec 31, 2018$243.84K+88.7%
Q2 FY2019CQ3 2018Sep 30, 2018$178.80K+6.1%
Q1 FY2019CQ2 2018Jun 30, 2018$194.78K+23.7%
Q4 FY2018CQ1 2018Mar 31, 2018$123.36K-29.9%
Q3 FY2018CQ4 2017Dec 31, 2017$129.21K-27.6%
Q2 FY2018CQ3 2017Sep 30, 2017$168.57K-49.4%
Q1 FY2018CQ2 2017Jun 30, 2017$157.46K+33.8%
Q4 FY2017CQ1 2017Mar 31, 2017$175.93K–
Q3 FY2017CQ4 2016Dec 31, 2016$178.44K–
Q2 FY2017CQ3 2016Sep 30, 2016$333.43K–
Q1 FY2017CQ2 2016Jun 30, 2016$117.66K–

More Aethlon Medical figures

See a number that looks wrong?